Browsing Tag
ANDA
2 posts
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Senores Pharmaceuticals (NSE: SENORES) launches Deferiprone Tablets in U.S. with Dr. Reddy’s Laboratories
Find out how Senores Pharmaceuticals Limited’s Deferiprone launch in the U.S. is reshaping its generics growth strategy. Read more for expert analysis!